Hyundai Motor India Limited (HMIL) has reported a resilient financial performance for the third quarter and nine months ended FY2025–26, backed by healthy volume growth, strong export momentum and an improved sales mix.
For Q3 FY26, the company posted EBITDA of ₹20,183 crore, up 7.6 per cent year-on-year, while net profit rose 6.3 per cent YoY to ₹12,344 crore. Revenue for the quarter stood at ₹1,79,735 crore, marking an 8.0 per cent YoY growth.
On a nine-month basis, HMIL recorded EBITDA of ₹66,325 crore, up 3.3 per cent YoY, with margins expanding to 12.8 per cent, despite higher costs linked to capacity stabilisation and elevated commodity prices. Net profit for the period stood at ₹41,759 crore, compared to ₹40,259 crore in the corresponding period last year.
Key Business Highlights
- Domestic demand remained strong, supported by GST 2.0 reforms and festive-season tailwinds, with wholesale volumes rising 5 per cent quarter-on-quarter, alongside robust retail traction.
- Hyundai CRETA reaffirmed its leadership, reclaiming its position as India’s best-selling SUV, achieving its highest-ever annual sales of over 200,000 units in CY2025.
- The new Venue received a strong market response, garnering nearly 80,000 bookings, with first-time buyers contributing 48 per cent of demand.
- Hyundai made a strategic entry into commercial mobility, introducing Prime HB and SD taxi offerings.
- Export performance remained robust, with volumes growing 21 per cent YoY in Q3 FY26, accounting for 25 per cent of the overall sales mix.
Financial Snapshot (Consolidated)
- Revenue (Q3 FY26): ₹1,79,735 crore (+8.0% YoY)
- EBITDA (Q3 FY26): ₹20,183 crore (+7.6% YoY)
- EBITDA Margin (Q3 FY26): 11.2%
- PAT (Q3 FY26): ₹12,344 crore (+6.3% YoY)
- Revenue (9M FY26): ₹5,18,472 crore
- EBITDA (9M FY26): ₹66,325 crore (+3.3% YoY)
- EBITDA Margin (9M FY26): 12.8%
- PAT (9M FY26): ₹41,759 crore
(EBITDA excludes other income)
Commenting on the results, Tarun Garg, Managing Director & CEO, Hyundai Motor India Limited, said: “The third-quarter performance reflects our resilience and disciplined execution of our ‘Quality of Growth’ strategy, supported by healthy growth in volumes, revenue and profitability. On a year-to-date basis, EBITDA margins expanded to 12.8 per cent, aided by an improved sales mix and prudent cost-control measures.
As we move ahead, the strong sales momentum witnessed in January 2026 provides us with confidence for a healthy growth trajectory in 2026.”
